XML 67 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combination - Purchase Price of Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Jun. 30, 2020
Dec. 31, 2019
Dec. 12, 2018
Business Acquisition [Line Items]        
Goodwill $ 55,053   $ 55,053 $ 55,053
Keryx Biopharmaceuticals, Inc.        
Business Acquisition [Line Items]        
Cash and cash equivalents       5,257
Inventory       235,597
Trade accounts receivable, net       15,834
Prepaid expenses and other current assets       8,399
Goodwill       55,053
Intangible assets:        
Developed product rights for Auryxia       329,130
Other intangible assets       545
Property and equipment, net       3,646
Other assets       14,441
Accounts payable       (17,570)
Accrued expenses       (42,972)
Deferred tax liability       (35,096)
Debt       (15,000)
Fair value of unfavorable executory contract $ (41,000) $ (41,500) $ (30,200) (29,510)
Total purchase price       $ 527,754